I'm a bit worried that Audion has been too quiet. Frequency has cut deals, made the news, is regularly going to conferences, and is gearing up for what looks like a roll out of FX-322. If you google for Audion, there's almost no news stories or buzz about them. If they have a drug that works, why are they being so quiet? Additionally, in Frequency's Phase I results, they played up how 4 of the individuals treated saw statistically significant improvements. There was nothing about patient improvements in the Audion Phase I results. The only indication we have that LY3056480 works is a second hand story from someone on this forum (which admittely is good intel, though why would someone whose hearing improved go back on tour to wreck it again?).



I poked around a little on LinkedIn, where Audion has a small presence. I noticed the CEO of Audion is also the CEO of another company. I'm not sure how common that is, but that seemed odd. Of the 3 employees listed, I looked at the activity of 2 of them and didn't see anything that really shed any light on big news coming.



Anyway, this is just me trying to read the tealeaves. I'm starting to wonder if we should expect disappointing results from Audion. If it wasn't for the story on this forum about a musican recovering, I would say it looks bad for Audion, though that leak seems to make it sound like they have something real - but if they have something that works, I don't understand why they'd be acting the way they are.

Click to expand...